NCT02584933 2026-04-02
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Active not recruiting
Clinical Trials
68 trialsNCT06031233 2026-03-30
MINUTE
Isala
Phase 4 Recruiting
NCT04813913 2026-02-06
VASCATAQ
University Hospital, Rouen
Phase 4 Completed
NCT04281017 2026-01-16
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
University of Florida
Phase 4 Recruiting
NCT07022938 2025-12-26
Nutritional Supplement for Treating Chemotherapy Induced Neuropathy
Aristotle University Of Thessaloniki
Phase 4 Completed
NCT04362072 2025-06-11
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Pfizer
Phase 4 Completed
NCT02312960 2025-03-25
Radium-223 Dichloride Long-term Follow-up Program
Bayer
Phase 4 Completed
NCT03849131 2025-03-12
PRAISE
University Hospital, Strasbourg, France
Phase 4 Active not recruiting
NCT06820255 2025-02-11
SELECTIO-UC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4 Recruiting
NCT06023368 2024-11-14
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
University of Kentucky
Phase 4 Withdrawn
NCT06118710 2024-09-25
DEXASTOP
Erasmus Medical Center
Phase 4 Recruiting
NCT05078671 2024-06-12
PROACTIVE
Radboud University Medical Center
Phase 4 Recruiting
NCT00942968 2024-04-18
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Pfizer
Phase 4 Completed
NCT00902720 2023-07-05
Ovarian Tissue Freezing For Fertility Preservation
Oregon Health and Science University
Phase 4 Unknown
NCT05844670 2023-05-06
CHAPATI
Moi University
Phase 4 Unknown
NCT02485444 2023-02-28
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
Ataturk University
Phase 4 Completed
NCT03145012 2023-02-08
Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Nova Scotia Health Authority
Phase 4 Completed
NCT05660694 2022-12-21
Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis
Altamash Institute of Dental Medicine
Phase 4 Completed
NCT03333655 2022-08-12
Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy
Hoffmann-La Roche
Phase 4 Completed
NCT02426034 2022-07-01
A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 4 Completed
NCT05082441 2021-10-19
Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection
Samaritan Health Services
Phase 4 Unknown
NCT01968798 2021-04-05
ACES
Hennepin Healthcare Research Institute
Phase 4 Unknown
NCT01739764 2021-01-07
An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Hoffmann-La Roche
Phase 4 Completed
NCT04699760 2021-01-07
The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer
University of Copenhagen
Phase 4 Completed
NCT01588184 2020-11-05
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
Hoffmann-La Roche
Phase 4 Completed
NCT03107325 2020-10-06
Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging
Boston Children's Hospital
Phase 4 Withdrawn
NCT03518684 2020-09-03
Obstetrical Gel Use to Shorten Labor and Prevent Lower Genital Tract Trauma
American University of Beirut Medical Center
Phase 4 Completed
NCT04256525 2020-06-30
Prophylactic Anticoagulation for Catheter-related Thrombosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT02815319 2020-04-28
REaCT-dex
Ottawa Hospital Research Institute
Phase 4 Completed
NCT04261920 2020-03-09
Clinical Trial Scheme of Huangqi Guizhi Wuwu Decoction
Jiangsu Famous Medical Technology Co., Ltd.
Phase 4 Unknown
NCT03831633 2019-02-06
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
VIFORFRANCE
Phase 4 Unknown
NCT03777930 2018-12-19
The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol
Shenzhen Fifth People's Hospital
Phase 4 Unknown
NCT00488384 2018-07-19
Acitretin Plasma Levels Under Hemodialysis
University of Zurich
Phase 4 Withdrawn
NCT02641938 2018-01-02
Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury
Gangnam Severance Hospital
Phase 4 Completed
NCT00198276 2017-10-03
Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Inovio Pharmaceuticals
Phase 4 Completed
NCT03106389 2017-05-09
Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy
Ain Shams Maternity Hospital
Phase 4 Unknown
NCT00241111 2017-03-06
Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
Novartis
Phase 4 Completed
NCT02088515 2017-03-03
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 4 Completed
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01675531 2016-12-16
A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Mundipharma Korea Ltd
Phase 4 Completed
NCT00944372 2016-09-09
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors
Mallinckrodt
Phase 4 Terminated
NCT01328054 2016-06-08
A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval
GlaxoSmithKline
Phase 4 Completed
NCT02173964 2016-04-15
Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)
Seoul National University Hospital
Phase 4 Completed
NCT01523912 2016-02-22
Radiofrequency Ablation for the Treatment of Gastric Dysplasia
Hospital Sao Joao
Phase 4 Completed
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02213653 2015-04-29
Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
Centre Francois Baclesse
Phase 4 Terminated
NCT02283424 2014-11-05
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
Chinese PLA General Hospital
Phase 4 Unknown
NCT02194556 2014-07-18
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01949974 2014-05-28
PAI
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4 Withdrawn
NCT00358111 2014-05-13
Study of LUMA Cervical Imaging System as Adjunct to Colposcopy
SpectraScience
Phase 4 Terminated